PRE TAX NTA |$3.62

Value as at close of business on 29 November 2024

Impact Video Series: Centre for Human Psychopharmacology

We interviewed leading individuals from our beneficiaries to discuss the importance of medical research, their recent breakthroughs and the vital need for private funding. In this video we talk to:

  • Professor Linda Kristjanson AO, Vice-Chanellor and President of Swinburne University of Technology
  • Professor Con Stough, Professor of Cognitive Neuroscience of Swinburne University's Centre for Human Psychopharmacology

Swinburne University's Centre for Human Psychopharmacology has been nominated by Core Fund Manager, Cooper Investors.

 

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
...